This is a demo store. No orders will be fulfilled.
USD
GBP
CNY
EUR
INR
JPY
MYR
ZAR
KRW
THB
Smartphone-based Solutions Spur the Global Infectious Disease Point-of-Care Testing Market, Forecast to 2024
Smartphone-based Solutions Spur the Global Infectious Disease Point-of-Care Testing Market, Forecast to 2024
COVID-19 and STDs among Millennials Speed Development of Miniaturized POCT Devices and Alternate Care Sites to Enable Transformational Growth
RELEASE DATE
14-Sep-2020
14-Sep-2020
REGION
North America
North America
Research Code: K4C6-01-00-00-00
SKU: HC03336-NA-MT_24714
$4,950.00
In stock
SKU
HC03336-NA-MT_24714
Description
The COVID-19 pandemic prompted a transformation in the infectious disease point-of-care testing (POCT) market. The shift towards miniaturized POCT devices will lead to the emergence of cost-effective integrated lab-on-a-chip devices based on microfluidic technologies and smartphone-based solutions enabling multiplexed detection of infectious pathogens. From RT-PCR to serology tests, and the beginning of new CRISPR-based diagnostics powered by artificial intelligence and machine learning algorithms, a high degree of sensitivity and specificity is possible. This shift is fostering notable market growth driven further by the possibility of alternate care sites that will provide more affordable and accessible point-of-care diagnostic tests. Genomics are expected to drive the innovation spectrum in this space, changing the paradigm of understanding host-pathogen interaction, creating opportunity for more personalized prevention. CRISPR-based diagnostic tests to detect SARS-CoV-2 have shown a specificity and sensitivity of 100% on clinical patients, and it is only a matter of time before such tests are implemented at a POC setting.
The infectious disease POCT market is a high growth ecosystem generating a compound annual growth rate (CAGR) of 27.3% from 2019 to 2024. Driven by the impact of the COVID-19 pandemic, the market is expected to witness a growth rate of 70.2% in 2020. Asia-Pacific (APAC) and the Rest of World (ROW) are expected to emerge as the fastest growing segment during the forecast period, primarily for carrying the greatest disease burden. Influenza, RSV, and CT are some of the key infectious diseases. The United States will lead the respiratory tract infection (RTI) POCT segment when compared to Europe whereas Europe will surpass the United States in the sexually transmitted infection (STI) POCT segment. India is expected to emerge as the fastest growing market for STI POCTs in APAC. The top 5 participants account for close to 85% of market share.
An increase in government funding is expected to boost infectious disease prevention and management, supported by a spike in STDs among the millennial generation. Although the RTI POCT segment dominates the infectious disease POCT market, increased vigilance is expected in the STI POCT segment. For POCT innovators, a mix-and-match implementation model is recommended, offering a blend of options chosen individually to best address the requirements of healthcare providers, technology innovators, and the general public, thereby supporting the sustainability of infectious disease POCT programs. Multiplexed POCTs made to detect multiple infectious pathogens from a single specimen will sustain long-term market growth.
Author: Amartya Bose
Table of Contents
Purpose of This Experiential Study
Methodology
5 Step Process to Transformational Growth
Key Findings—Vision Transformation and Market Overview
Study Scope and Segmentation
Key Infectious Disease Segments
Key Questions this Study will Answer
Infectious Disease POCT Market—Where Is the Market Heading?
Strategic Imperatives for Infectious Disease POCT Stakeholders
Market Definitions
Infectious Disease POCT Market—Vendor Ecosystem, Global
Market Engineering Measurements
Total POCT Market Snapshot
Infectious Disease POCT Market—Percent Revenue by Segment and Region
Infectious Disease POCT Market—Percent Revenue by Region for RTI and STI Segments
POCT Adoption and COVID-19 Market Opportunity
Impact of COVID-19 on Infectious Disease POCT Market
Revenue Forecast Assumptions—COVID-19 POCT
COVID-19 Market Size Estimates—Scenario 1
COVID-19 Market Size Estimates—Scenario 2
COVID-19 POCT Market Revenue Estimates by Region
COVID-19 Diagnostic Testing Overview
Value Chain Analysis
Key Drivers and Restraints
Key Technology Trends in the Global Infectious Disease POCT Market
Key Technology Trends in the Global Infectious Disease POCT Market (continued)
Market Engineering Measurements
Revenue Forecast Assumptions
Revenue Forecast
Revenue Forecast
Revenue Forecast by Application
Revenue by Region
The United States—Percent Revenue by Disease Area
The United States—Percent Incidence by Disease Area
Europe—Percent Revenue by Disease Area
Europe—Percent Incidence by Disease Area
Top Vendors—Product Portfolio Assessment
Revenue Forecast
Revenue Forecast by Application
Revenue by Region
The United States—Percent Revenue by Disease Area
The United States—Percent Incidence by Disease Area
Europe—Percent Revenue by Disease Area
Europe—Percent Incidence by Disease Area
Top Vendors—Product Portfolio Assessment
The United States—Revenue Forecast
The United States—Revenue Forecast Discussion
Europe—Revenue Forecast
Europe—Revenue Forecast Discussion
APAC & ROW—Revenue Forecast
APAC & ROW—Revenue Forecast Discussion
Competitor Overview
Competitive Factors Assessment
Key Companies to Watch, Global
Key Companies to Watch, Global (continued)
Key Companies to Watch, Global (continued)
Key Products to Watch in Infectious Disease POCT
Key Products to Watch in Infectious Disease POCT (continued)
Notable Activities
Macro to Micro Visioning
Trends/Factors Impacting the Infectious Disease POCT Market
Business Model Essential for POCT Vendors
Key Regulatory Developments and Future Implications
Top Predictions for the Infectious Disease POCT Market
Levers for Growth
Growth Opportunity 1—Multiplexed POCT
Growth Opportunity 2—COVID-19 POCT
Growth Opportunity 3—Millennials and STIs
Growth Opportunity 4—STI POCTs in India
Growth Opportunity 5—Digital POCT
Brand and Demand—Growth Opportunities
Major Growth Opportunities Discussed
Identifying Your Company’s Growth Zone
Growth Opportunities 1-5—Vision and Strategy
Growth Opportunities 1-5—Brand and Demand
Growth Opportunities Matrix
Growth Strategies for Your Company
Prioritized Opportunities through Implementation
Legal Disclaimer
RTI POCT—Competitive Product Matrix for Key Infectious Diseases
RTI POCT—Competitive Product Matrix for Key Infectious Diseases (continued)
STI POCT—Competitive Product Matrix for Key Infectious Diseases
STI POCT—Competitive Product Matrix for Key Infectious Diseases (continued)
STI POCT—Competitive Product Matrix for Key Infectious Diseases (continued)
Abbreviations and Acronyms Used
Abbreviations and Acronyms Used (continued)
List of Exhibits
List of Exhibits (continued)
List of Exhibits (continued)
Popular Topics
The COVID-19 pandemic prompted a transformation in the infectious disease point-of-care testing (POCT) market. The shift towards miniaturized POCT devices will lead to the emergence of cost-effective integrated lab-on-a-chip devices based on microfluidic technologies and smartphone-based solutions enabling multiplexed detection of infectious pathogens. From RT-PCR to serology tests, and the beginning of new CRISPR-based diagnostics powered by artificial intelligence and machine learning algorithms, a high degree of sensitivity and specificity is possible. This shift is fostering notable market growth driven further by the possibility of alternate care sites that will provide more affordable and accessible point-of-care diagnostic tests. Genomics are expected to drive the innovation spectrum in this space, changing the paradigm of understanding host-pathogen interaction, creating opportunity for more personalized prevention. CRISPR-based diagnostic tests to detect SARS-CoV-2 have shown a specificity and sensitivity of 100% on clinical patients, and it is only a matter of time before such tests are implemented at a POC setting.
The infectious disease POCT market is a high growth ecosystem generating a compound annual growth rate (CAGR) of 27.3% from 2019 to 2024. Driven by the impact of the COVID-19 pandemic, the market is expected to witness a growth rate of 70.2% in 2020. Asia-Pacific (APAC) and the Rest of World (ROW) are expected to emerge as the fastest growing segment during the forecast period, primarily for carrying the greatest disease burden. Influenza, RSV, and CT are some of the key infectious diseases. The United States will lead the respiratory tract infection (RTI) POCT segment when compared to Europe whereas Europe will surpass the United States in the sexually transmitted infection (STI) POCT segment. India is expected to emerge as the fastest growing market for STI POCTs in APAC. The top 5 participants account for close to 85% of market share.
An increase in government funding is expected to boost infectious disease prevention and management, supported by a spike in STDs among the millennial generation. Although the RTI POCT segment dominates the infectious disease POCT market, increased vigilance is expected in the STI POCT segment. For POCT innovators, a mix-and-match implementation model is recommended, offering a blend of options chosen individually to best address the requirements of healthcare providers, technology innovators, and the general public, thereby supporting the sustainability of infectious disease POCT programs. Multiplexed POCTs made to detect multiple infectious pathogens from a single specimen will sustain long-term market growth.
Author: Amartya Bose
| No Index | No |
|---|---|
| Podcast | No |
| Author | Amartya Bose |
| Industries | Healthcare |
| WIP Number | K4C6-01-00-00-00 |
| Is Prebook | No |
| GPS Codes | 9600-B1,9562-B1,9573-B1,99C6-B1,9627-B1 |